Skip to main content

Aggressive Versus Conservative Blood Pressure Reduction in Acute Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal
Critical care medicine (Q1)
Published
22 July 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Gabriel Semione, Marcio Yuri Ferreira, Ahmet Gunkan, Marina Vilardo, Luiz Henrique da Silva Tobaldini, Gabriel Lebkuchen, et al.
PMID
42484370
DOI
10.1097/CCM.0000000000007240

Why clinicians should know about it

Abstract

OBJECTIVES: Intracerebral hemorrhage carries high mortality and long-term disability. The optimal blood pressure (BP) management strategy-aggressive vs. conservative lowering-remains uncertain. This review compares both strategies. DATA SOURCES: Articles from PubMed, Web of Science, Embase, and Cochrane were screened to August 2025. STUDY SELECTION: Only randomized open-label blinded-endpoint trials were included. DATA EXTRACTION: Patient characteristics, inclusion criteria, interventions, and outcomes were independently extracted by two authors; conflicts were resolved by a third. DATA SYNTHESIS: Eight randomized controlled trials (12,669 patients; median age 63 yr; 60% male) met inclusion. No significant differences emerged between aggressive and conservative strategies for excellent functional outcome (risk ratio [RR], 1.07; 95% CI, 0.99-1.16; p = 0.94; I2 = 33%), good functional outcome (RR, 1.09; 95% CI, 0.99-1.20; p = 0.07; I2 = 51%), 90-day mortality (RR, 0.90; 95% CI, 0.77-1.05; p = 0.18; I2 = 0%), or hematoma growth (RR, 0.85; 95% CI, 0.66-1.10; p = 0.22; I2 = 48%). Aggressive BP lowering was associated with fewer adverse events (RR, 0.87; 95% CI, 0.76-0.99; p = 0.03; I2 = 59%). Sensitivity analyses showed significant benefits of the aggressive approach for good recovery (RR, 1.05; 95% CI, 1.01-1.10; p = 0.02; I2 = 0%), although not confirmed in the subgroup analyses (RR, 1.09; 95% CI, 0.97-1.23; p = 0.14; I2 = 61%). For adverse events, subgroup analyses consistently favored the aggressive strategy (RR, 0.81; 95% CI, 0.74-0.88; p < 0.01; I2 = 0%). No clear association with hematoma growth emerged, largely due to heterogeneity. CONCLUSIONS: Aggressive and conservative BP lowering yielded similar outcomes for functional recovery, mortality, and hematoma growth. Aggressive BP lowering was linked to fewer adverse events, with some subgroup analyses suggesting modest functional benefits.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.